Diarrhea News and Research

Latest Diarrhea News and Research

Handwashing education in Pakistan decreased the incidence of diarrhea by more than 50 percent among children

An intensive program of handwashing education and promotion in Pakistan decreased the incidence of diarrhea by more than 50 percent among children, according to a study in the June 2 issue of the Journal of the American Medical Association (JAMA), a theme issue on Global Health.

1 Jun 2004

Most Americans are not meeting their dietary needs for calcium

According to government surveys, 70 percent of girls and 60 percent of boys ages 6-11 do not meet current calcium recommendations.

31 May 2004

Anti-inflammatory medicine Roflumilast improved lung function in patients with chronic obstructive pulmonary disease

ALTANA AG’s investigational anti-inflammatory medicine roflumilast improved lung function in patients with Chronic Obstructive Pulmonary Disease (COPD) according to a placebo controlled study presented at the annual meeting of the American Thoracic Society (ATS).

25 May 2004

Foodborne diseases pose a serious threat to densely populated areas of Asia and the Pacific

Foodborne diseases pose a serious threat to densely populated areas of Asia and the Pacific, two UN agencies said today. ''So far, food contamination incidents and food-borne disease outbreaks in the region have been relatively isolated, but the potential danger is just round the corner.

25 May 2004

KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates

Results from an ongoing surveillance study, PROTEKT US (Prospective Resistant Organism Tracking and Epidemiology of the Ketolide Telithromycin – United States) Year 2 (2001-2002), suggest that KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates, including those resistant to other antimicrobial agents.

24 May 2004

Significant symptom relief reported in clinical trial patients with irritable bowel syndrome

Solvay Pharmaceuticals unveiled this week results from a six-month study of both male and female patients and from a subgroup analysis of males with Irritable Bowel Syndrome with Diarrhea predominance (IBS-D).

24 May 2004

Helminthic therapy, using worm eggs to treat patients with inflammatory bowel disorders

University of Iowa Health Care researchers reported important findings recently at a conference of specialists in New Orleans, La. The findings are from their study of helminthic therapy - using specially prepared worm eggs - to treat patients diagnosed with inflammatory bowel disorders that don't respond to standard treatments.

21 May 2004

WHO reports likely Ebola case in Sudan

As of 10 May, WHO reported cases of Ebola haemorrhagic fever syndrome in Hai-Cuba, Yambio, Western Equatoria Region, south Sudan. A rapid assessment team is in the field to investigate the situation. Clinical samples have been collected and preliminary results are expected soon.

21 May 2004

FDA issues gastrointestinal illness alert regarding raw basil in Texas and Illinois

The FDA is issuing an alert to consumers that two outbreak clusters of a gastrointestinal illness known as cyclosporiasis may be associated with raw basil and mesculin/spring mix salad served in Texas and Illinois. The agency is working with the U.S. Centers for Disease Control and Prevention and state and other health authorities to determine the cause and scope of the problem.

21 May 2004

Zinc may help to accelerate recovery from pneumonia

The addition of zinc to standard antimicrobial treatment may accelerate recovery from pneumonia, say researchers in this week's issue of The Lancet.

20 May 2004

Study has important implications for African Americans who suffer from high blood pressure

A new study has important implications for the millions of African Americans who suffer from high blood pressure. The study, AADVANCE, shows Diovan HCT(R) (valsartan and hydrochlorothiazide) lowers blood pressure in African Americans to aggressive recommended target blood pressure goals as effectively as amlodipine.

20 May 2004

FDA approves new drug for bone marrow disease

The Food and Drug Administration (FDA) today announced the approval of Vidaza (azacitidine) injection, the first effective treatment for patients with Myelodysplastic Syndrome (MDS). The product was given Fast Track Status and a priority review.

19 May 2004

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

Centocor, Inc., and Schering-Plough Corporation announced today the initiation of the SONIC (Study of Immunomodulator Naive patients in Crohn's Disease) trial that will evaluate the efficacy of REMICADE® (infliximab) versus azathioprine, a conventional immunosuppressive agent, alone and versus the combination of both drugs for the treatment of patients with Crohn's disease.

18 May 2004

Researchers receive almost £1 million in funding for Irritable Bowel Syndrome

Researchers at The University of Nottingham, England have picked up almost £1 million in funding for a number of studies into a painful and distressing bowel condition that will affect up to one in 10 of the population at some time or another.

11 May 2004

All Black urges allergy sufferers to play it safe

All Black Kees Meeuws is fronting an Allergy New Zealand poster campaign urging allergy sufferers to play it safe and protect a life as part of Allergy Awareness Week, which kicks off May 10, 2004. The poster sports a bare-chested and tattooed Kees with his six-week-old daughter, Inéz (who is now three months old).

10 May 2004

Discovery of immune system malfunction that plays a profound role in food allergy

A team of scientists, led by the Institute of Food Research (IFR) in the UK, has discovered an immune system malfunction that is likely to play a profound role in food allergy.

8 May 2004

New license agreement for rotavirus diarrhea vaccine

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), announced today a new license agreement aimed at helping to prevent hundreds of thousands of deaths annually from rotavirus diarrhea in children living in developing countries.

4 May 2004

Breastfeeding can reduce the risk of death for infants in their first year of life

Data analyzed by scientists at the National Institute of Environmental Health Sciences suggest that breastfeeding can reduce the risk of death for infants in their first year of life. Looking at infants between 28 days and one year of age, researchers concluded that promoting breastfeeding can potentially prevent up to 720 postneonatal deaths in the U.S. each year.

3 May 2004

Sanitation measures are critical to preventing an outbreak of avian influenza

People with small backyard flocks including those who raise chickens, geese, ducks, turkeys and other fowl can play an important role in protecting the state's commercial poultry industry. Mike Hackett, Washington State University Snohomish County Extension educator, says strict sanitation measures are critical to preventing an outbreak of avian influenza.

30 Apr 2004

FDA updates Zelnorm labeling a treatment of women with irritable bowel syndrome

The Food and Drug Administration (FDA) today announced the addition of new risk information to the health professional labeling for Zelnorm (tegaserod maleate). Zelnorm is a prescription medication for the short-term treatment of women with irritable bowel syndrome (IBS) whose primary bowel symptom is constipation.

30 Apr 2004

Diarrhea News and Research

Latest Diarrhea News and Research

Handwashing education in Pakistan decreased the incidence of diarrhea by more than 50 percent among children

Most Americans are not meeting their dietary needs for calcium

Anti-inflammatory medicine Roflumilast improved lung function in patients with chronic obstructive pulmonary disease

Foodborne diseases pose a serious threat to densely populated areas of Asia and the Pacific

KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates

Significant symptom relief reported in clinical trial patients with irritable bowel syndrome

Helminthic therapy, using worm eggs to treat patients with inflammatory bowel disorders

WHO reports likely Ebola case in Sudan

FDA issues gastrointestinal illness alert regarding raw basil in Texas and Illinois

Zinc may help to accelerate recovery from pneumonia

Study has important implications for African Americans who suffer from high blood pressure

FDA approves new drug for bone marrow disease

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

Researchers receive almost £1 million in funding for Irritable Bowel Syndrome

All Black urges allergy sufferers to play it safe

Discovery of immune system malfunction that plays a profound role in food allergy

New license agreement for rotavirus diarrhea vaccine

Breastfeeding can reduce the risk of death for infants in their first year of life

Sanitation measures are critical to preventing an outbreak of avian influenza

FDA updates Zelnorm labeling a treatment of women with irritable bowel syndrome

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Diarrhea News and Research

Latest Diarrhea News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in